🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareMy 18-month semaglutide journey — comprehensive data log Page 2

My 18-month semaglutide journey — comprehensive data log

DataDave Sun, Jun 7, 2026 at 11:03 AM 20 replies 526 viewsPage 2 of 4
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Jun 7, 2026 at 5:17 PM#6
LipidDoc_ATL said:
The mechanism that matters here is not stomach emptying, it is central.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

46 16josh_phd_bmore, roxy_nash, tony_orlando and 43 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jun 7, 2026 at 7:45 PM#7

The figures, for anyone assembling their own picture. Worth knowing that the injection site changes very little. Abdomen, thigh and upper arm are bioequivalent for semaglutide, so a site change is not a plausible explanation for a bad week.

45 15Dr.PulmRoch, maya_sedona, stefan_berlin and 42 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Jun 7, 2026 at 10:13 PM#8
TirzTom said:
I will push back on the "any working dose is fine" framing.

Coming at TirzTom’s question from a different direction. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

Last edited: Jun 8, 2026 at 4:13 AM
44 14Dr.LipidDallas, alex_tucson, kevin_tulsa and 41 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
tom_AK
New Member
28
112
Jan 2026
Anchorage, AK
Jun 8, 2026 at 12:41 AM#9

One thing that is still open after mike_nyc’s answer:

What would you measure differently if you were starting again?

43 13jennifer_SEA, tyler_CSCS, VanRx_Mike and 40 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Jun 8, 2026 at 12:33 PM#10

Reporting back.

Update since I posted: I held at 1.7mg for a further twelve weeks and lost another 4kg slowly, which settles it for me. I was escalating because the number was available, not because I had stopped responding.

7 7Dr.GutHealth, amsterdam_pete, LondonLisa and 4 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
What I wish I knew before starting GLP-1 therapy14 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register